Bryan R. Haugen

Affiliations: 
University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Oncology, Molecular Biology
Google:
"Bryan Haugen"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Leboulleux S, Boucai L, Busaidy N, et al. (2025) Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement. The Lancet. Diabetes & Endocrinology
White SL, Jamil T, Bell C, et al. (2025) Population prevalence of the major thyroid cancer-associated syndromes. The Journal of Clinical Endocrinology and Metabolism
Bell C, White SL, Tylee T, et al. (2025) Thyroid Nodule Sphericity Metrics Discriminate Benign and Malignant Follicular and Oncocytic Neoplasms. Thyroid : Official Journal of the American Thyroid Association
White SL, Jamil T, Bell C, et al. (2024) Prevalence of the major thyroid cancer-associated syndromes in the United States. Medrxiv : the Preprint Server For Health Sciences
Barrio MJ, Pozdeyev N, Raeburn CD, et al. (2024) Pre-operative thyroglobulin measurement for thyroid cancer risk of recurrence and response to therapy. American Journal of Surgery. 115818
French JD, Haugen BR, Worden FP, et al. (2024) Combination Targeted Therapy with Lenvatinib and Pembrolizumab in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Bischoff LA, Ganly I, Fugazzola L, et al. (2024) Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma: A Review and Multidisciplinary 2023 Update. Jama Otolaryngology-- Head & Neck Surgery
Greca A, Grau L, Arbet J, et al. (2023) Anthropometric, dietary, and lifestyle factors and risk of advanced thyroid cancer: The NIH-AARP diet and health cohort study. Clinical Endocrinology
Pozdeyev N, Dighe M, Barrio M, et al. (2023) Thyroid cancer polygenic risk score improves classification of thyroid nodules as benign or malignant. The Journal of Clinical Endocrinology and Metabolism
Jeon MJ, Haugen BR. (2022) Preclinical Models of Follicular Cell-Derived Thyroid Cancer: An Overview from Cancer Cell Lines to Mouse Models. Endocrinology and Metabolism (Seoul, Korea). 37: 830-838
See more...